Literature DB >> 9391104

In vivo telomere dynamics of human hematopoietic stem cells.

R Notaro1, A Cimmino, D Tabarini, B Rotoli, L Luzzatto.   

Abstract

Aging in vivo and cell division in vitro are associated with telomere shortening. Several lines of evidence suggest that telomere length may be a good predictor of the long term replicative capacity of cells. To investigate the natural fate of chromosome telomeres of hematopoietic stem cells in vivo, we measured the telomere length of peripheral blood granulocytes from 11 fully engrafted bone marrow transplant recipients and from their respective donors. In 10 of 11 donor-recipient pairs, the telomere length was significantly reduced in the recipient and the extent of reduction correlated inversely with the number of nucleated cells infused. These data provide internally controlled in vivo evidence that, concomitantly with their proliferation, hematopoietic stem cells lose telomere length; it is possible that, as a result, their proliferative potential is reduced. These findings must be taken into account when developing new protocols in which few stem cells are used for bone marrow transplantation or for gene therapy.

Entities:  

Mesh:

Year:  1997        PMID: 9391104      PMCID: PMC28384          DOI: 10.1073/pnas.94.25.13782

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  DECLINE IN COLONY-FORMING ABILITY OF MARROW CELLS SUBJECTED TO SERIAL TRANSPLANTATION INTO IRRADIATED MICE.

Authors:  L SIMINOVITCH; J E TILL; E A MCCULLOCH
Journal:  J Cell Comp Physiol       Date:  1964-08

2.  The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats.

Authors:  G B Morin
Journal:  Cell       Date:  1989-11-03       Impact factor: 41.582

3.  Pulsed field gel electrophoresis techniques for separating 1- to 50-kilobase DNA fragments.

Authors:  B W Birren; E Lai; L Hood; M I Simon
Journal:  Anal Biochem       Date:  1989-03       Impact factor: 3.365

4.  A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes.

Authors:  R K Moyzis; J M Buckingham; L S Cram; M Dani; L L Deaven; M D Jones; J Meyne; R L Ratliff; J R Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

5.  The fate of serially transplanted bone marrow cell populations from young and old donors.

Authors:  D A Ogden; H S Mickliem
Journal:  Transplantation       Date:  1976-09       Impact factor: 4.939

Review 6.  The molecular structure of centromeres and telomeres.

Authors:  E H Blackburn
Journal:  Annu Rev Biochem       Date:  1984       Impact factor: 23.643

7.  The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity.

Authors:  C W Greider; E H Blackburn
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

8.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

9.  Structure and variability of human chromosome ends.

Authors:  T de Lange; L Shiue; R M Myers; D R Cox; S L Naylor; A M Killery; H E Varmus
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

10.  Loss of stem cell repopulating ability upon transplantation. Effects of donor age, cell number, and transplantation procedure.

Authors:  D E Harrison; C M Astle
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

View more
  39 in total

Review 1.  Mammalian cell dedifferentiation as a possible outcome of stress.

Authors:  Ofer Shoshani; Dov Zipori
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

2.  Probing the mitotic history and developmental stage of hematopoietic cells using single telomere length analysis (STELA).

Authors:  Mark Hills; Kai Lücke; Elizabeth A Chavez; Connie J Eaves; Peter M Lansdorp
Journal:  Blood       Date:  2009-04-09       Impact factor: 22.113

Review 3.  Telomerase reverse transcriptase as target for anti-tumor T cell responses in humans.

Authors:  Maurizio Zanetti; Xavier Hernandez; Pierre Langlade-Demoyen
Journal:  Springer Semin Immunopathol       Date:  2005-02-15

4.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.

Authors:  Lindsay M Morton; Wael Saber; K Scott Baker; A John Barrett; Smita Bhatia; Eric A Engels; Shahinaz M Gadalla; David E Kleiner; Steven Pavletic; Linda J Burns
Journal:  Biol Blood Marrow Transplant       Date:  2016-09-12       Impact factor: 5.742

Review 5.  Aging stem cells, latexin, and longevity.

Authors:  Ying Liang; Gary Van Zant
Journal:  Exp Cell Res       Date:  2008-02-19       Impact factor: 3.905

6.  Dynamics of epigenetic age following hematopoietic stem cell transplantation.

Authors:  Friedrich Stölzel; Mario Brosch; Steve Horvath; Michael Kramer; Christian Thiede; Malte von Bonin; Ole Ammerpohl; Moritz Middeke; Johannes Schetelig; Gerhard Ehninger; Jochen Hampe; Martin Bornhäuser
Journal:  Haematologica       Date:  2017-05-26       Impact factor: 9.941

7.  Stem cells from birth to death: The history and the future.

Authors:  Gerald de Haan; Gary Van Zant
Journal:  J Am Aging Assoc       Date:  2002-04

8.  Sustained in vitro trigger of self-renewal divisions in Hoxb4hiPbx1(10) hematopoietic stem cells.

Authors:  Sonia Cellot; Jana Krosl; Jalila Chagraoui; Sylvain Meloche; R Keith Humphries; Guy Sauvageau
Journal:  Exp Hematol       Date:  2007-05       Impact factor: 3.084

Review 9.  Telomere diseases.

Authors:  Rodrigo T Calado; Neal S Young
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

10.  Mutations in C16orf57 and normal-length telomeres unify a subset of patients with dyskeratosis congenita, poikiloderma with neutropenia and Rothmund-Thomson syndrome.

Authors:  Amanda J Walne; Tom Vulliamy; Richard Beswick; Michael Kirwan; Inderjeet Dokal
Journal:  Hum Mol Genet       Date:  2010-09-03       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.